The man who founded a biotech that got sold to Eli Lilly for $8 billion reveals why he's staying on at the pharma giant
6:57am PST - January 18th, 2020 super bowl 2019 - Business InsiderLoxo Oncology CEO Josh Bilenker sold his company to pharma giant Eli Lilly in January 2019 in an $8 billion deal that came together in just 18 days. A year later, Bilenker is still with Lilly, serving as the company's head of oncology research under the Loxo …